165 related articles for article (PubMed ID: 35379282)
1. Differential humanistic and economic burden of mild, moderate and severe haemophilia in european adults: a regression analysis of the CHESS II study.
Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
Orphanet J Rare Dis; 2022 Apr; 17(1):148. PubMed ID: 35379282
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study.
Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
Orphanet J Rare Dis; 2022 Apr; 17(1):150. PubMed ID: 35379284
[TBL] [Abstract][Full Text] [Related]
3. Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.
Burke T; Asghar S; O'Hara J; Chuang M; Sawyer EK; Li N
Orphanet J Rare Dis; 2021 Dec; 16(1):521. PubMed ID: 34930388
[TBL] [Abstract][Full Text] [Related]
4. Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.
Burke T; Shaikh A; Ali TM; Li N; Curtis R; Garcia Diego DA; Recht M; Sannie T; Skinner M; O'Hara J
J Med Econ; 2022; 25(1):386-392. PubMed ID: 35253589
[TBL] [Abstract][Full Text] [Related]
5. The humanistic and economic burden of problem joints for children and adults with moderate or severe haemophilia A: Analysis of the CHESS population studies.
Chowdary P; Nissen F; Burke T; Aizenas M; Czirok T; Dhillon H; O'Hara J
Haemophilia; 2023 May; 29(3):753-760. PubMed ID: 36897517
[TBL] [Abstract][Full Text] [Related]
6. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
7. The cost of severe haemophilia in Europe: the CHESS study.
O'Hara J; Hughes D; Camp C; Burke T; Carroll L; Diego DG
Orphanet J Rare Dis; 2017 May; 12(1):106. PubMed ID: 28569181
[TBL] [Abstract][Full Text] [Related]
8. Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys.
Burke T; Asghar S; O'Hara J; Sawyer EK; Li N
Orphanet J Rare Dis; 2021 Mar; 16(1):143. PubMed ID: 33743752
[TBL] [Abstract][Full Text] [Related]
9. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study.
Young L; Chen Y; Alvir J; Burke T; Ferri Grazzi E; Winburn I
Orphanet J Rare Dis; 2023 Aug; 18(1):227. PubMed ID: 37537683
[TBL] [Abstract][Full Text] [Related]
10. Humanistic burden of problem joints for children and adults with haemophilia.
Burke T; Rodriguez-Santana I; Chowdary P; Curtis R; Khair K; Laffan M; Mclaughlin P; Noone D; O'Mahony B; Pasi J; Skinner M; O'Hara J
Haemophilia; 2023 Mar; 29(2):608-618. PubMed ID: 36574369
[TBL] [Abstract][Full Text] [Related]
11. Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study.
Peral C; De Lossada Juste A; Lwoff N; Espinoza-Cámac N; Casado MÁ; Burke T; Alvir J; Thakkar S; Ferri Grazzi E
J Health Econ Outcomes Res; 2024; 11(1):122-133. PubMed ID: 38721331
[No Abstract] [Full Text] [Related]
12. The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis.
Culpepper L; Martin A; Nabulsi N; Parikh M
Adv Ther; 2024 May; 41(5):1860-1884. PubMed ID: 38466558
[TBL] [Abstract][Full Text] [Related]
13. Haemophilia A: health and economic burden of a rare disease in Portugal.
Café A; Carvalho M; Crato M; Faria M; Kjollerstrom P; Oliveira C; Pinto PR; Salvado R; Dos Santos AA; Silva C
Orphanet J Rare Dis; 2019 Sep; 14(1):211. PubMed ID: 31484564
[TBL] [Abstract][Full Text] [Related]
14. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.
O'Hara J; Walsh S; Camp C; Mazza G; Carroll L; Hoxer C; Wilkinson L
Health Qual Life Outcomes; 2018 May; 16(1):84. PubMed ID: 29720192
[TBL] [Abstract][Full Text] [Related]
15. The economic and humanistic burden of bipolar disorder in adults in the United States.
Dembek C; Mackie D; Modi K; Zhu Y; Niu X; Grinnell T
Ann Gen Psychiatry; 2023 Mar; 22(1):13. PubMed ID: 36964564
[TBL] [Abstract][Full Text] [Related]
16. Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.
Lopes N; Dias LLS; Azulay-Abulafia L; Oyafuso LKM; Suarez MV; Fabricio L; Kobata CM; Cestari T; Gontijo B; Sabbag CY; Antonio JR; Romiti R; Pertel PC
Adv Ther; 2019 Oct; 36(10):2849-2865. PubMed ID: 31432463
[TBL] [Abstract][Full Text] [Related]
17. The societal burden of haemophilia A. II - The cost of moderate and severe haemophilia A in Australia.
Brown LJ; La HA; Li J; Brunner M; Snoke M; Kerr AM
Haemophilia; 2020 Aug; 26 Suppl 5():11-20. PubMed ID: 32935398
[TBL] [Abstract][Full Text] [Related]
18. The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease.
Henrard S; Devleesschauwer B; Beutels P; Callens M; De Smet F; Hermans C; Speybroeck N
Orphanet J Rare Dis; 2014 Mar; 9():39. PubMed ID: 24655371
[TBL] [Abstract][Full Text] [Related]
19. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
Booth J; Oladapo A; Walsh S; O'Hara J; Carroll L; Garcia Diego DA; O'Mahony B
Haemophilia; 2018 Sep; 24(5):e322-e327. PubMed ID: 30091822
[TBL] [Abstract][Full Text] [Related]
20. Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres.
Nerich V; Tissot E; Faradji A; Demesmay K; Bertrand MA; Lorenzini JL; Briquel ME; Pouzol P; Woronoff-Lemsi MC
Pharm World Sci; 2008 Jun; 30(3):287-92. PubMed ID: 18085428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
